| Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 22 | Dec 21 | |
|---|---|---|---|
| Revenue | |||
| Cost of revenue | |||
| Operating income | |||
| Operating margin | |||
| Net income | |||
| Net profit margin | |||
| Cash on hand | |||
| Change in cash | |||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 11.47 mm | 11.47 mm | 11.47 mm | 11.47 mm | 11.47 mm | 11.47 mm |
| Cash burn (monthly) | 1.70 mm | 994.25 k | 2.39 mm | 2.78 mm | 1.70 mm | 3.23 mm |
| Cash used (since last report) | 29.08 mm | 16.97 mm | 40.83 mm | 47.49 mm | 28.98 mm | 55.08 mm |
| Cash remaining | -17.61 mm | -5.50 mm | -29.36 mm | -36.02 mm | -17.51 mm | -43.61 mm |
| Runway (months of cash) | -10.3 | -5.5 | -12.3 | -12.9 | -10.3 | -13.5 |
| 13F holders | Current |
|---|---|
| Total holders | 22 |
| Opened positions | 6 |
| Closed positions | 7 |
| Increased positions | 2 |
| Reduced positions | 3 |
| 13F shares | Current |
|---|---|
| Total value | 9.46 bn |
| Total shares | 201.69 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| Accelmed Partners II | 122.19 mm | $0.00 |
| New Enterprise Associates 13 | 34.44 mm | $14.12 mm |
| NEA Management | 34.44 mm | $8.82 bn |
| CNVT CVF | 2.26 mm | $0.00 |
| Vivo Ventures Vii | 2.22 mm | $20.72 mm |
| AWM Investment | 2.11 mm | $0.00 |
| Versant Venture Capital IV | 1.67 mm | $8.60 mm |
| Versant Venture Management | 1.67 mm | $428.80 mm |
| STT State Street | 161.80 k | $41.44 mm |
| Geode Capital Management | 128.75 k | $32.97 mm |
